Mead Johnson Nutrition Company (MJN) Shares are Down -1.77%

Mead Johnson Nutrition Company (MJN) : During the past 4 weeks, traders have been relatively bearish on Mead Johnson Nutrition Company (MJN), hence the stock is down -4.33% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -2.19% relative to the S&P 500. The 4-week change in the price of the stock is -1.95% and the stock has fallen -1.77% in the past 1 week.

Mead Johnson Nutrition Company (NYSE:MJN): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $87.80 and $87.41 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $88.52. The buying momentum continued till the end and the stock did not give up its gains. It closed at $87.62, notching a gain of 0.18% for the day. The total traded volume was 1,205,649 . The stock had closed at $87.46 on the previous day.

The stock has recorded a 20-day Moving Average of 3.03% and the 50-Day Moving Average is 0.32%. Mead Johnson Nutrition Company is up 3.53% in the last 3-month period. Year-to-Date the stock performance stands at 12.14%.

Mead Johnson Nutrition Company (MJN) : 7 investment research analysts covering Mead Johnson Nutrition Company (MJN) have an average price target of $90.86 for the near short term. The highest target price given by the Brokerage Firm to the stock is $105 and the lowest target is $75 for the short term. Analysts expect the variance to be within $9.04 of the average price.


Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.